TY  - GEN
AU  - Hamaguchi,Tetsuya
AU  - Denda,Tadamichi
AU  - Kudo,Toshihiro
AU  - Sugimoto,Naotoshi
AU  - Ura,Takashi
AU  - Yamazaki,Kentaro
AU  - Fujii,Hirofumi
AU  - Kajiwara,Takeshi
AU  - Nakajima,Takako Eguchi
AU  - Takahashi,Shin
AU  - Otsu,Satoshi
AU  - Komatsu,Yoshito
AU  - Nagashima,Fumio
AU  - Moriwaki,Toshikazu
AU  - Esaki,Taito
AU  - Sato,Takeo
AU  - Itabashi,Michio
AU  - Oki,Eiji
AU  - Sasaki,Toru
AU  - Chiron,Marielle
AU  - Yoshino,Takayuki
TI  - Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer
SN  - 1349-7006
PY  - 2019///1112
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Asian People
KW  - Biomarkers, Tumor
KW  - blood
KW  - Camptothecin
KW  - analogs & derivatives
KW  - Colonic Neoplasms
KW  - Fluorouracil
KW  - Humans
KW  - Insulin-Like Growth Factor Binding Protein 1
KW  - Interleukin-8
KW  - Japan
KW  - Kallikreins
KW  - Leucovorin
KW  - Placenta Growth Factor
KW  - Prognosis
KW  - Progression-Free Survival
KW  - Prospective Studies
KW  - Pulmonary Surfactant-Associated Protein D
KW  - Receptor for Advanced Glycation End Products
KW  - Receptors, Tumor Necrosis Factor, Type II
KW  - Receptors, Vascular Endothelial Growth Factor
KW  - Recombinant Fusion Proteins
KW  - Rectal Neoplasms
KW  - Regression Analysis
KW  - Tenascin
KW  - Tissue Inhibitor of Metalloproteinase-1
KW  - Vascular Endothelial Growth Factor Receptor-1
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1111/cas.14198
ER  -